Cite
HARVARD Citation
Sufficool, K. et al. (n.d.). Histopathologic characteristics of therapy‐associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma. Journal of cutaneous pathology. pp. 568-575. [Online].